Pfizer and the Challenges of the Global Pharmaceutical Industry Overview and Objectives The Pfizer case provides an introduction to external analysis. The case highlights the pharmaceutical industry‚ which has enjoyed extraordinary long-run profitability. The case also demonstrates how broad changes in broad environmental factors (i.e. demographics‚ technology‚ culture‚ etc.) have an impact on industry competition. The case is not especially complex‚ so it is not overwhelming as a first case
Premium Strategic management Pharmaceutical industry
Tough on Crime? Pfizer and the CIHR. Healthc Policy [online] 2010 May; 5(4): 16–25. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875889/ [Accessed Oct 26 2012]. Esteban‚ D.‚ 2008. Strengthening corporate social responsibility in the pharmaceutical industry. Journal of Medical Marketing‚ 8(1)‚ pp. 77-79. Kelton‚ E. 2012. Forbes. Big Pharma ’s Offshore Fraud Strategy. [online] Available at: http://www.forbes.com/sites/erikakelton/2012/09/11/big-pharmas-offshore-fraud-strategy/ [Accessed Oct
Premium Business ethics Corporate social responsibility Social responsibility
Lipitor-X Product Launch Plan Pfizer Inc is the largest research based biomedical and pharmaceutical company in the world. Headquartered in New York‚ Pfizer has major research and development locations in England and the United States. Since its inception in 1849‚ the organization has remained dedicated to discovering and developing new and better ways to prevent and treat disease‚ while helping to improve health and well being for people around the world. In November‚ the Pfizer
Premium Marketing People's Republic of China Pharmaceutical industry
RESEARCH TOPIC An In-depth-study of OTC medicine segment of Indian Pharmaceutical Industry with special emphasis on consumer behavior RESEARCH OBJECTIVES Macro objective To study the Indian Pharmaceutical Industry as a whole Micro objectives To understand the consumer’s attitude towards OTC products of the pharmaceutical industry To understand the healthcare products’ contribution and also its effects on pharmaceutical market To determine the extent to which the respondents prefer self-medication
Premium Pharmaceutical industry Pharmacology Generic drug
The Betapharm Acquisition: DRL ’s Inorganic Growth Strategy in Europe DRL GAINS A FOOTHOLD IN EUROPE On February 15‚ 2006‚ Dr. Reddy ’s Laboratories Limited (DRL)‚ a leading Indian pharmaceutical company‚ acquired the fourth-largest generic pharmaceutical company in Germany‚ betapharm Arzneimittel GmbH (betapharm) from the 3i Group PLC (3i) for US$570 million (480 million). The deal also included the beta institute for socio medical research GmbH ’ (beta Institute)‚ a non-profit research
Premium Generic drug Pharmaceutical industry
The case consists of two major pharmaceutical companies that joint to collaborate their research and pharmaceutical technologies to start a joint venture in India. Both have valuable resources that have benefited both companies during the joint venture. Now both are questioning if there is still any value in maintaining the joint venture in India and will be deciding what will be the best route to take. Ranbaxy Laboratories wants to be bought out‚ but Eli Lilly is worried of the financial implications
Premium Generic drug Pharmaceutical industry Clinical trial
Brian Lam A Critique of Strong Patent Protection Abstract In this paper‚ I attempt to analyze the negatives and positives of patent protection. The discussion will include an analysis of impact to firms and profits‚ particularly in the pharmaceutical sector‚ their innovations as a result‚ and the ultimate impact to society. Traditionally‚ it is believed that stringent patent regulations hurt the profits of large biotechnology companies‚ giving them less of an incentive to innovate. As a result
Premium Generic drug Patent Pharmaceutical industry
OBJECTIVE: Through this study‚ we have tried to compare and analyse the following 3 ratios for 5 pharmaceutical companies’ vis-à-vis the industry average for these ratios. 1. Debt-Equity ratio‚ 2. Current ratio‚ and 3. Interest coverage ratio The 5 companies analysed include: 1. Vivimed Labs 2. Anuh Pharma 3. Tonira Pharma 4. Lincoln Pharmaceuticals 5. Dishman Pharmaceuticals & Chemicals FACTS AND ASSUMPTIONS: As for the industry averages and industry best ratios
Premium Pharmaceutical industry Pharmacology Pharmacy
Individual Research Proposal Introduction In this day and age‚ we cannot deny that technology is a key aspect of our daily lives and has definitely made our lives more efficient and convenient in several aspects. 61 million individuals are using mobile phones for health related topics‚ 29 million patients exchange emails with physicians‚ and 9 million consumers use health communities online (Nicole Lucarelli). However‚ many pharmacies are currently not exploiting technology to benefit their companies
Premium Facebook Pharmaceutical industry Social media
Been Adopted With A View To Encourage Fair Competition At The International Level‚ But Trips Rules Tilt The Balance In Favour Of Imperfect Competition With Each Country And Exacerbates International Inequalities. (Discussion With Reference To Pharmaceutical Industry) Name of Lecturer : Rajendran K S Name of Student : Nilesh Singh Date of Submission : 6 May 2011 Table of Contents 1. | Introduction | 3 | | 1.1 Main Objective of This Essay | 3 | 2. | Role of TRIPs
Premium Pharmaceutical industry Patent Generic drug